Search clinical trials for: IP2018

Total 34 results

Initiator Pharma

Recruiting

Clinical Trial Studying the Efficacy and Safety of IP2018 in Depressed, Erectile Dysfunction (ED) Patients

Erectile Dysfunction

United Kingdom
Initiator Pharma

Not yet recruiting

Bioavailability Study to Compare Liquid vs Two Solid Formulations of IP2015

Bioavailability
Sandoz
Hexal AG

Completed

Clinical Trial to Compare Treatment With GP2017 and Humira® in Patients With Rheumatoid Arthritis (ADMYRA)

Rheumatoid Arthritis

United States, United Kingdom, Hungary, Italy, Malaysia, Serbia, Mexico, Spain, Czechia, Poland, Germany, Romania, Russian Federation
Intelligem Therapeutics Australia Pty Ltd.

Not yet recruiting

A Dose Escalation Study of IG3018 in Subjects With Hyperuricemia With or Without Chronic Kidney Disease

Hyperuricemia | Hypouricemia, Renal
University of Genova

Unknown

Tracheostomy in ICU With a Double Lumen Endotracheal Tube

Heart Failure | Acute Respiratory Failure | Neurological Disease

Italy
Medicines for Malaria Venture
Richmond Pharmacology Limited

Completed

A FIH Study to Investigate the Safety, Tolerability and PK of P218

Malaria

United Kingdom
Initiator Pharma

Not yet recruiting

Study to Investigate the Pharmacodynamic Effects of IP2015 in Healthy Male Subjects Using the Intradermal Capsaicin Model

Pain
Sandoz

Completed

Comparative Efficacy and Safety Study of GP2015 and Enbrel® in Patients With Rheumatoid Arthritis (EQUIRA)

Rheumatoid Arthritis

Estonia, Italy, Lithuania, United Kingdom, United States, Bulgaria, Czechia, Poland, Slovakia, Spain, Latvia, Serbia, Hungary, Russian Federation, Mexico, Germany
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity of Fluzone® Quadrivalent, Flublok® Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines, 2018-2019 Formulations (GRC90)

Influenza

United States
Sandoz
Hexal AG

Completed

Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira (ADACCESS)

Plaque Type Psoriasis

United States, France, Bulgaria, Slovakia
Sandoz
Hexal AG

Completed

Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Etanercept (GP2015) and Enbrel (EGALITY)

Chronic Stable Plaque Psoriasis

Germany, Romania, Bulgaria, Czech Republic, Estonia, Hungary, Poland, Russian Federation, Slovakia, South Africa, Ukraine, United Kingdom
Nanfang Hospital, Southern Medical University

Recruiting

The Diagnostic Value of APTT/Fibrinogen Ratio in Pulmonary Embolism

Acute Pulmonary Embolism

China
Sandoz
Novartis Pharmaceuticals

Completed

GP2013 in Japanese Patients With CD20 Positive Low Tumor Burden Indolent B-cell Non-Hodgkin's Lymphoma

Indolent B-cell Non-Hodgkin's Lymphoma

Japan
Medicines for Malaria Venture
Washington University School of Medicine; Sanaria Inc.; Institute of Tropical... and other collaborators

Completed

Safety, Tolerability and Chemoprotective Activity of P218 in PfSPZ Challenge Model

Malaria

Belgium
University of Southern Denmark
University of Copenhagen; University of Aarhus; The Danish Institute for Quality...

Unknown

The Effectiveness of a Nationwide Mandatory Accreditation in General Practice in Denmark (ACIAP)

Quality Control
British Columbia Centre for Disease Control
McGill University Health Centre/Research Institute of the McGill University... and other collaborators

Active, not recruiting

TITRE III: Influenza B Immunogenicity Investigation

Influenza

Canada
Sandoz
Novartis Pharmaceuticals

Completed

GP2013 in the Treatment of RA Patients Refractory to or Intolerant of Standard Therapy

Rheumatoid Arthritis

United States, Spain, Turkey, Argentina, Austria, Belgium, Brazil, Estonia, France, Germany, Hungary, India, Italy, Romania
Sandoz
Novartis Pharmaceuticals

Completed

GP2013 in the Treatment of Patients With Previously Untreated, Advanced Stage Follicular Lymphoma (ASSIST_FL) (ASSIST_FL)

Follicular Lymphoma

Russian Federation, Netherlands, Peru, United Kingdom, Romania, Brazil, Malaysia, Spain, India, Italy, Bulgaria, Poland, South Africa, Japan, Argentina, Australia, Austria, Colombia, France, Germany, Greece, Hungary, Ireland, Israel, Po... and more
MedImmune LLC
AstraZeneca

Completed

Evaluate the Shedding and Immunogencity of Different Formulations of FluMist in Children 24 to <48 Months of Age (FluMist)

Healthy | Influenza

United States
Hebrew University of Jerusalem

Unknown

Group Based Parent Training for Children With Autism and Disruptive Behaviors

Autism Spectrum Disorder

Israel
Novartis Pharmaceuticals

Completed

Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar) (SURPASS)

Ankylosing Spondylitis

Taiwan, Netherlands, United Kingdom, Germany, Korea, Republic of, Israel, United States, Belgium, Greece, Philippines, Russian Federation, Spain, Turkey, Portugal, Mexico, Peru, Denmark, France, Czechia, Australia, Canada, Poland, J... and more
Assiut University

Completed

Prognostic Significance of Bioscore in Nonmetastatic Breast Cancer (Observational)

Breast Cancer

Egypt
Shanghai Jiao Tong University School of Medicine

Completed

PT-CY With or Without Low-dose ATG for Lymphoid Malignancies Undergoing Allo-HSCT

GVHD, Acute

China
Duke University
Centers for Disease Control and Prevention; Children's Hospital Medical Center...

Completed

Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women (Tdap/IIV)

Pregnancy

United States
Sandoz
Hexal AG

Completed

GP2013 Treatment in Patients With Active Rheumatoid Arthritis, Previously Treated With Rituxan® or MabThera® (ASSIST-RT)

Rheumatoid Arthritis

United States, Germany, Poland, Hungary
McMaster University
Canadian Institutes of Health Research (CIHR)

Recruiting

Relative Impacts on Preventative Primary Care--a Longitudinal Evaluation of COVID-19:Phase 1 (RIPPLE-C)

Diabetes Mellitus | Chronic Kidney Diseases | Chronic Obstructive Pulmonary Disease | Osteoarthritis | Dementia | Congestive Heart Failure | Depression, Anxiety

Canada
Sanofi Pasteur, a Sanofi Company

Completed

Study of Recombinant Influenza Vaccine Containing Different H3 Antigens Without or With Adjuvant in Healthy Adult Subjects (FBP00004)

Healthy Volunteers | Influenza Immunisation

United States
University Hospital Bispebjerg and Frederiksberg

Withdrawn

Changes in Cerebral Blood Flow (CBF) in Prone and Sitting Position Before and After GSP-block and Before and After Epidural Blood-patch: A Substudy of NCT03652714

Postdural Puncture Headache | Sphenopalatine Ganglion Block

Denmark
Michigan State University

Recruiting

Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?

Sepsis | Systemic Inflammatory Response Syndrome | Infection, Bacterial | Infection, Coronavirus | Infection, Fungal | Infection Mixed

United States
The University of Hong Kong
Prince of Wales Hospital, Shatin, Hong Kong; Queen Mary Hospital, Hong Kong; Tuen... and other collaborators

Recruiting

Impact of Early Sepsis Care Guided by the National Early Warning Score 2 in the Emergency Department (NEWS-1-TRIPS)

Sepsis | Septic Shock

Hong Kong
Abbott Diagnostics Division

Completed

Abbott Laboratories Alinity s Blood Screening Assays - Clinical Evaluation Protocol

Healthy

United States
Sanofi Pasteur, a Sanofi Company

Completed

Recombinant Influenza Vaccine Containing Different H3 Antigens in Healthy Adults 18 to 30 Years of Age (FBP00001)

Influenza

United States
University of Michigan
Planned Parenthood Federation of America; National Opinion Research Center

Recruiting

Michigan Contraceptive Access, Research, and Evaluation Study Children: Phase 1 (M-CARES-K)

Pregnancy

United States
University of Michigan
National Opinion Research Center

Active, not recruiting

Michigan Contraceptive Access, Research, and Evaluation Study: Phase 1 (M-CARES)

Pregnancy

United States

Search clinical trials for: IP2018

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uruguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations